Human fragile WWOX gene encodes a tumor suppressor WW domain-containing oxidoreductase (named WWOX, FOR, or WOX1). Functional suppression of WWOX prevents apoptotic cell death induced by a variety of stress stimuli, such as tumor necrosis factor, UV radiation, and chemotherapeutic drug treatment. Loss of WWOX gene expression due to gene deletions, loss of heterozygosity, chromosomal translocations, or epigenetic silencing is frequently observed in human malignant cancer cells. Acquisition of chemoresistance in squamous cell carcinoma, osteosarcoma, and breast cancer cells is associated with WWOX deficiency. WWOX protein physically interacts with many signaling molecules and exerts its regulatory effects on gene transcription and protein stability and subcellular localization to control cell survival, proliferation, differentiation, autophagy, and metabolism. In this review, we provide an overview of the recent advances in understanding the molecular mechanisms by which WWOX regulates cellular functions and stress responses. A potential scenario is that activation of WWOX by anticancer drugs is needed to overcome chemoresistance and trigger cancer cell death, suggesting that WWOX can be regarded as a prognostic marker and a candidate molecule for targeted cancer therapies.
Introduction
Human WWOX gene resides in a common fragile site FRA16D on chromosome 16q23.3-24.1. The WWOX gene contains nine exons spanning over one million bases of human chromosomal DNA and encodes a tumor suppressor WW domain-containing oxidoreductase (designated as WWOX, FOR, or WOX1). [1] [2] [3] [4] The full-length 46-kDa WWOX protein consists of two N-terminal WW domains, a nuclear localization sequence between the WW domains, and a C-terminal short-chain alcohol dehydrogenase/reductase (SDR) domain ( Figure 1 ). The C-terminal region of WWOX protein encoded by exons 5-8 is frequently deleted or alternatively spliced in a variety of human cancer cells. 4, 5 In contrast, the WW domain region is rarely deleted.
WW domains are small protein modules that consist of $40 amino acids with a pair of highly conserved tryptophan residues spaced 20-23 amino acids apart and show a triplestranded antiparallel b-sheet conformation. 6 Specific protein-protein interactions mediated through the binding of WW domains to proline-containing motifs have been found to be associated with various cellular functions, including regulation of transcription factors (TCF), protein ubiquitination, and cell growth control. 6, 7 WW domains can be classified into four groups according to their binding specificity for peptide ligands. 8 Proteins with group I WW domains, such as dystrophin, Yes-associated protein (YAP65), and Nedd4 E3 ubiquitin ligase, have been shown to interact with peptide motifs containing Pro-Pro-X-Tyr (PPXY, where X represents any amino acid) or Leu-Pro-X-Tyr (LPXY). Group II WW domains mediate binding to PPLP motifs and group III WW domains mediate binding to PPR motifs. Group IV WW domains recognize p(S/T)P motifs. Group I WW domains have been studied most intensively. The first WW domain of WWOX protein has been reported to interact with various PPXY motif-containing proteins, such as p73, activator protein 2g (AP2g), ErbB-4, ezrin, small membrane protein of the lysosome/late endosome (SIMPLE), and Dishevelled 1 (DVL1) (Figure 1 ). [9] [10] [11] [12] [13] [14] A recent study suggested that WWOX binds to LPXY motifcontaining proteins, such as the E3 ubiquitin ligase ITCH, via its first WW domain (Figure 1 ). 14 WW domain interactions with PPXY motif can be regulated by phosphorylation of tyrosine residues within the group I WW domains. 8 Phosphorylation of Tyr33 in the first WW domain of WWOX has been demonstrated to be crucial for its binding to p53, c-Jun N-terminal kinase 1 (JNK1) and p73 ( Figure 1 ). 9, 15, 16 However, no PPXY or LPXY is identified in p53 and JNK1. Src phosphorylates WWOX at Tyr33 in the first WW domain. 9 Structural analysis has revealed that Tyr33 within the first WW domain of WWOX is engaged in key intermolecular contact with the proline residues within PPXY motifs of target proteins. 17 The second WW domain of WWOX has an atypical structure with the replacement of a signature tryptophan by tyrosine. A recent study has demonstrated that the second WW domain of WWOX serves as a chaperone in a context of tandem module to enhance binding of the first WW domain to the PPXY motifs within the intracellular domain of receptor tyrosine kinase ErbB-4. 17 The C-terminal SDR domain has been shown to mediate the binding of WWOX with Tau for regulating Tau hyperphosphorylation ( Figure 1 ). 18 WWOX also binds to glycogen synthase kinase 3b (GSK-3b) via its SDR domain to inhibit GSK-3b-mediated Tau phosphorylation ( Figure 1 ). 19 Bouteille et al. 20 demonstrated that both WW and SDR domains of WWOX protein interact with DVL2 ( Figure 1 ). Many SDR family proteins catalyze reactions that regulate cellular metabolism and redox functions. Whether WWOX exerts its enzymatic function via binding to its interacting proteins, such as Tau, GSK-3b, and DVL2, for regulating steroid metabolism and redox balance is unclear and remains to be clearly characterized.
WWOX functions as a tumor suppressor
Chromosomal fragility has been suggested to be associated with cancer development. Frequent deletions, loss of heterozygosity, and translocations of human WWOX gene have been found in numerous types of cancers, including hepatoma (28.7%), breast tumors (81.8%), esophageal squamous cell carcinoma (SCC) (38.9%), non-small-cell lung cancer (37%), pancreatic adenocarcinoma (26.7%), and gastric carcinoma (30.8%). 4, 21 Mutations in the exons and noncoding regions of human WWOX gene have been identified in the SCC and non-small-cell lung cancer samples. 4, 22 Promoter hypermethylation of WWOX gene may cause the reduced expression of WWOX in cancer cells. [23] [24] [25] Poor prognosis or unfavorable clinical outcome in patients is associated with low or absent expression of WWOX in cancer specimens. [26] [27] [28] [29] Aberrant WWOX transcripts have been noted in breast, ovarian, lung, pancreatic, and other cancers. 4, 30, 31 High expression levels of two alternatively transcribed WWOX variants have been identified in human breast tumors, suggesting that these variant proteins may be involved in cancer progression. 32 However, the stability and function of these truncated proteins have yet to be determined.
Ablation of Wwox gene has been shown to cause higher tumor incidence in mice. 33 There was occurrence of spontaneous osteosarcomas in juvenile Wwox À/À and lung papillary carcinomas in adult Wwox þ/À mice. 33 However, all whole-body Wwox gene knockout mice died by four weeks of age. Restoration of Wwox expression by the infection of a recombination adenovirus carrying Wwox cDNA has been demonstrated to suppress tumor growth in lung and breast cancer xenograft mouse models, suggesting that WWOX is a bona fide tumor suppressor. 34, 35 
WWOX regulates cell apoptosis in stress responses
WWOX has been reported to be involved in stress responses. UV light exposure significantly upregulates WWOX protein expression in hairless mouse epidermis. 36 Constant light-induced retinal degeneration is associated with nuclear and mitochondrial accumulation of Tyr33phosphorylated Wwox protein in rodent photoreceptors. 37 Upon sciatic nerve transection in rats, significant upregulation of Wwox expression has been detected in the injured neurons. 38 Treatment of a dopaminergic neurotoxin 1-methyl-4-phenyl-pyridinium (MPP þ ) increases Wwox protein expression and phosphorylation at Tyr33 in rat brains. 39 Complement C1q treatment induces cluster formation of WWOX-containing microvilli on the cell membrane of prostate cancer cells. 40 Together, these studies have revealed that WWOX is activated via phosphorylation at Tyr33 and translocates to the cell membrane, mitochondria, and nucleus under stress conditions ( Figure 2 ). Substantial evidence suggests that WWOX plays an important role in the regulation of cell apoptosis. WWOX enhances the cytotoxic function of tumor necrosis factor (TNF) in L929 fibroblasts via its WW and SDR domains. 3 The enhancement of TNF cytotoxicity by WWOX is due to its significant downregulation of the apoptosis inhibitors Bcl-2 and Bcl-xL but upregulation of the proapoptotic p53. 3 WWOX physically interacts with p53 during stress responses and both proteins induce cell death synergistically ( Figure 2 ). 15 Phosphorylation of WWOX at Tyr33 is crucial for its enhancing effect on p53 protein stability during TNF-and staurosporine-mediated cell death. 15 Ectopically overexpressed WWOX induces caspase activation and apoptosis in cancer cells, and inhibits the growth of lung, breast, prostate, and pancreatic tumors in nude mice. 23, 34, 35, 41 Suppression of WWOX expression by antisense mRNA and small interfering RNA (siRNA) protects cells from apoptosis induced by TNF, staurosporine, UV light, and ectopic p53 in vitro. 3, 15, 36 The inhibition of cell apoptosis by dominant negative mutants and a short synthetic peptide that have been shown to suppress Tyr33 phosphorylation of WWOX also indicates a critical role of WWOX phosphorylation in the regulation of cell death. 15, 39, 40 WWOX controls the functional activities of p53 family proteins WWOX has been demonstrated to regulate transcriptional factor activities for controlling a variety of cellular physiological functions. The first identified transcription factor was p53, a well-known proapoptotic mediator. 3 p53 functions as a potent tumor suppressor that regulates a large number of target genes involved in apoptosis, cell cycle control, DNA repair, cellular senescence, angiogenesis, and metabolism. Upon binding to consensus p53responsive elements present in target gene promoters, p53 activates gene transcription of many downstream targets including the cyclin-dependent kinase inhibitor p21 Waf1/Cip1 and E3 ubiquitin protein ligase MDM2. p53 may also induce the expression of mediators that trigger apoptosis, such as BAX and PUMA. In response to DNA damages and stress signals, activation and stabilization of p53 protein are prerequisite for p53 functions. Treatment of cells with TNF-a, UV irradiation, staurosporine, anisomycin, chemotherapeutic drugs, hypoxia induces protein phosphorylation of WWOX at Tyr33. 15, 36, 42 Tyr33-phosphorylated WWOX is essential for binding and stabilizing Ser46-phosphorylated p53 (Figure 2 ). 15 The active WWOX-p53 complexes then translocate into the nucleus where they promote apoptosis ( Figure 2 ). 3, 15 The environmental cue leading to protein phosphorylation is crucial for coordinating the functions of tumor suppressors p53 and WWOX. 17b-estradiol has been shown to activate WWOX via binding to the conserved NSYK motif in SDR domain and trigger nuclear translocation of WWOX-p53 complexes in COS7 cells. 43 A recent report showed that WWOX overexpression increases the expression levels of p73, PUMA, and BAX in gallbladder cancer cells. 44 The presence of WWOX is inversely correlated with the mRNA expression levels of cyclins D1 and E1 in neuroblastoma. 25 Whether WWOX regulates the expression of genes involved in cell cycle regulation and apoptosis via p53 remains to be verified.
Tyr33-phosphorylated WWOX also binds p73, a p53 homolog, and this interaction induces apoptosis. 9 WWOX interacts with the 484 PPPPY 488 motif of p73 via its first WW domain, and phosphorylation of WWOX at Tyr33 is important for their physical association ( Figure 2 ). 9 In contrast to stress-induced nuclear translocation of WWOX-p53 complexes, ectopic WWOX inhibits the transcriptional activity of p73 by preventing its nuclear translocation ( Figure 2 ). 9 Cytoplasmic p73 exerts its proapoptotic activity with WWOX in SAOS-2 cells. 9 The E3 ligase ITCH mediates Lys63-linked ubiquitination of WWOX and induces nuclear relocation of WWOX for enhancing p73-induced cell death in HEK293 cells. 14 p63 is another protein in the p53 family that binds WWOX. 45 The p53 family members share similar structures, but may have distinct biological functions. Striking defects have been observed in p63-null embryos, suggesting its crucial role in embryonic development. In addition, p63 is required for maintaining epithelial cell homeostasis and keratinocyte differentiation. The TP63 gene encompasses two promoters that generate two protein isoforms. 46 The full-length TAp63 protein contains the N-terminal transcriptional transactivation (TA) domain, a DNAbinding domain and an oligomerization domain. The ÁNp63 isoform is produced by the use of the second promoter located in intron 3. The resulting N-terminal truncated protein lacks the TA domain for transactivation. 46 TAp63 has been shown to inhibit tumorigenesis and cancer cell metastasis, suggesting its role as a tumor suppressor. Interestingly, the ÁNp63a isoform may function as a dominant negative factor conteracting the tumor suppressor activities of p53 family proteins to promote cell survival and proliferation. 46 WWOX has been shown to interact with ÁNp63a but not TAp63a via its first WW domain ( Figure  1 ). 45 However, no PPXY or LPXY motif is identified in the unique N-terminus of ÁNp63a. Mutations in the PPXY motif within the C-terminal common region of TAp63a and ÁNp63a failed to disrupt the binding of WWOX to ÁNp63a, suggesting that WWOX may interact with a different motif rather than the canonical proline-rich motifs (Figure 1 ). 45 The interaction of WWOX with ÁNp63a has been demonstrated to sequester ÁNp63a in the cytoplasm, thereby suppressing ÁNp63a transactivation of target genes (Figure 2 ). 45 WWOX stabilizes ÁNp63a by inhibiting ITCH-mediated polyubiquitination and degradation of ÁNp63a. 45 Co-expression of WWOX and ÁNp63a significantly increases cisplastin-induced apoptosis in human osteosarcoma SAOS-2 cells as compared with the cells expressing ÁNp63a or WWOX alone. 45 Whether the binding of WWOX to ÁNp63a blocks the dominant-negative effect of ÁNp63a on proapoptotic TAp63a is unclear.
WWOX has been linked to the regulation of many TCF WWOX inhibits the transactivation function of AP2g by sequestering it in the cytoplasm, thus preventing the binding of AP2g to the ERBB2 promoter region and downregulating AP2g/ErbB2-mediated prostate cancer cell growth ( Figure 2 ). 10, 47 Tyr33-phosphorylated WWOX binds to the 
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PPPYFPPPY 64 peptide sequence of AP2g. 10 WWOX binding to AP2g downregulates androgen receptor-mediated growth signaling in LNCaP cells. 47 In basal-like breast cancer cells, elevated nuclear AP2g expression may be partially due to the reduced WWOX expression, indicating that the formation of WWOX-AP2g complexes is involved in the regulation of basal-like breast cancer development. 48 UV irradiation induces phosphorylation of Wwox at Tyr33 in hairless mouse epidermis. 36 Following exposure to UV irradiation, WWOX interacts with the PPVY motif of phosphorylated c-Jun and attenuates MEKK1-stimulated binding of c-Jun to an AP-1 element in human HaCaT keratinocytes ( Figure 2 ). 49 After sciatic nerve transection in rats, TCF NF-kB, ATF3, and phosphorylated c-Jun, and CREB rapidly accumulate in the nuclei of injured neurons. 38 Wwox is also upregulated in the dorsal root ganglion (DRG) neurons within hours. 38 Phosphorylated Wwox protein blocks the prosurvival CREB-and AP-1-mediated promoter activation, indicating concurrent activation of Wwox with TCF for regulating apoptosis of small DRG neurons upon neuronal injury in rats. 38 WWOX has been reported to suppress retroviral oncoprotein Tax-mediated tumorigenesis. 50 Tax protein is encoded by human T-cell leukemia virus type I (HTLV-I). Persistent activation of both canonical and noncanonical NF-kB pathways by HTLV-1 tax has been linked to the pathogenesis of adult T-cell leukemia. WWOX inhibits Tax-mediated recruitment of IKK-a to RelA and subsequent RelA phosphorylation at Ser536, thereby suppressing HTLV-1 Tax-induced activation of the canonical NF-kB pathway (Figure 2 ). 50 Interestingly, Tax-induced activation of noncanonical NF-kB pathway suppresses WWOX expression in lymphoma cells to promote tumorigenesis. 50 The receptor tyrosine kinase ErbB4 mediates the signals of neuregulins and other epidermal growth factor-like ligands, and regulates many cellular activities, including cell proliferation, differentiation, and migration. Upon ligand binding, proteolytically released intracellular domain of ErbB4 may translocate into the nucleus and regulate gene transcription. WWOX interacts with the PPXY motif in the intracellular domain of ErbB4 via its first WW domain, and this binding causes cytoplasmic retention of ErbB4 (Figure 2 ). 11 Substitution of Tyr33 with Arg33 in the first WW domain of WWOX abolishes the association of WWOX with ErbB4. 11 YAP is a WW domain-containing protein that also binds to the PPXY motif of ErbB4 and acts as a transcriptional co-activator. WWOX competes with YAP for interaction with ErbB4, and this competition modulates the transactivation function of ErbB4 (Figure 2 ). 11 The presence of WWOX protein in clinical breast cancer samples has been shown to be associated with localization of ErbB4 at the cell membrane and breast cancer survival. 27 Runt-related transcription factor 2 (RUNX2) is a key transcription factor associated with osteoblast differentiation and bone homeostasis. Wwox knockout mice display elevated RUNX2 levels in femurs, decreased trabecular bone density and abnormal bone metabolism. 51, 52 WWOX physically associates with RUNX2 and suppresses its transcriptional activity (Figure 2 ). 51 Ectopic WWOX expression in osteosarcoma cells downregulates RUNX2 expression, cell proliferation, and invasion. 52 An inverse correlation between WWOX and RUNX2 expression in human osteosarcoma tissue samples suggests the physiological relevance and the potential prognostic value in patients with osteosarcoma. 52 Hedgehog signaling is an essential and highly conserved signaling pathway involved in many developmental processes. When sonic hedgehog ligand binds to Ptch receptor, the zinc-finger transcription factor GLI1 is activated by release from a large protein complex and translocates into the nucleus to regulate gene expression. GLI1 also plays important roles in cell cycle progression and cancer metastasis. Aberrant expression of GLI1 has been found in many human cancers. WWOX directly interacts with GLI1 protein and triggers redistribution of nuclear GLI1 to the cytoplasm in breast cancer cells (Figure 2) . 53 In addition, ectopic WWOX downregulates mRNA levels of GLI1. 53 The molecular mechanism by which WWOX suppresses GLI1 expression and function for regulating breast cancer cell growth is largely unclear.
WWOX has been linked to the regulation of glucose metabolism. 54 Warburg effect is a hallmark of cancer cells manifested by high rates of aerobic glycolysis and high levels of lactate and pyruvate generation. WWOX physically interacts with hypoxia-inducible transcription factor 1a (HIF-1a) and suppresses HIF-1a-mediated transcriptional activation of downstream targets such as glucose transporter 1 (GLUT1) (Figure 2 ). 54 The reduced expression of GLUT1 leads to the downregulation of glucose uptake and glycolysis in cells. 54 HIF-1a upregulation induced by loss of WWOX expression is associated with tumorigenesis in mice. 54 How WWOX controls HIF-1a expression is unclear. WWOX deficiency decreases mitochondrial respiration in mouse embryonic fibroblasts. 54 The mechanism by which WWOX regulates oxidative phosphorylation in the mitochondria remains to be further investigated.
WWOX participates in multiple signaling pathways
WWOX has been suggested to be involved in many signaling pathways that regulate cell proliferation, embryonic development, metabolism, and apoptosis. 4 WWOX is a downstream effector in TNF signaling pathway and capable of enhancing TNF cytotoxicity. 3 TNF and UV light induce physical association of a zinc finger-like protein Zfra with WWOX and their translocation to the mitochondria. 55 Zfra is a 31-amino-acid protein that belongs to the C2H2 zinc-finger protein family. 56 Zfra is ubiquitously expressed in many organs and tissues, including the brain, heart, intestine, liver, lung, spleen, and testis. 56 Zfra has been shown to participate in TNF signaling and modulate the apoptotic functions of death domain-containing proteins, such as TRADD (TNF receptor-associated death domain protein), FADD (Fas-associated death domain-containing protein) and RIP (receptor interacting protein). 57 Transiently overexpressed Zfra induces apoptosis, and Ser8 phosphorylation is essential for its apoptotic function. 57 In response to the treatment of TNF and UV light, cytosolic Zfra is Ser8-phosphorylated and translocates to the mitochondria. When co-overexpressed in cells, Zfra and WWOX nullified each other's apoptotic function (Figure 2) . 55 This appears to be related with the Zfra/ WWOX interaction and suppression of WWOX nuclear localization by Zfra ( Figure 2 ). 55 Zfra also blocks WWOXinduced cytochrome c release from the mitochondria. 57 Similarly, TNF and UV light induce Zfra to rapidly selfassociate and bind p53, and JNK1. 55 Ectopic Zfra inhibits phosphorylation and nuclear translocation of p53 and its apoptotic effects in certain cells. In contrast, a Ser8 mutant of Zfra has no blocking effect. 55 WWOX has been demonstrated to physically interact with TRADD. 55 The WWOX/TRADD interaction enhances the apoptotic pathway triggered by TNF. 3 Moreover, inhibition of JNK by SP600129 enhances WWOX-induced apoptosis. 58 Indeed, JNK1 binds Tyr33phosphorylated WWOX and inhibits WWOX-mediated apoptosis (Figure 2 ). 16 Transforming growth factor beta (TGF-b has been demonstrated to stimulate nuclear accumulation of Tyr33phosphorylated WWOX and Smad4 in L929 fibroblasts. 59 Interestingly, TGF-b1 induces nuclear translocation of Tyr33-phosphorylated WWOX in type II TGF-b receptor (TbRII)-deficient HCT116 cells, indicating that TGF-b binds to an alternative receptor and stimulates WWOX activation. 59 The binding of TGF-b1 to cell surface hyaluronidase Hyal-2 on microvilli results in recruitment of WWOX and formation of Hyal-2-WWOX complexes for relocation to the nucleus (Figure 2 ). 59 Substitution of Tyr33 in the first WW domain of WWOX with arginine abolishes Hyal-2-WWOX complex formation, suggesting that Tyr33 phosphorylation is essential for Hyal-2-WWOX interaction. 59 Previous studies have shown that, in response to TGF-b stimulation, activated Src is translocated to the cytoplasmic membrane to phosphorylate its substrates TbRII and focal adhesion proteins. 60, 61 Whether Src phosphorylates WWOX at Tyr33 after TGF-b1 stimulation and regulates TGF-b1-induced formation of Hyal-2-WWOX complexes remains to be determined. WWOX and Hyal-2 synergistically enhance the promoter activity driven by Smad, which subsequently leads to cell death. 59 Transient overexpression of WWOX and Hyal-2 increases TGF-b1induced apoptosis in L929 cells. WWOX-knockdown in normal epithelial cells prevents growth suppression and apoptosis caused by TGF-b1, as well as by overexpressed Smad4. These findings suggest that TGF-b1 invokes a novel signaling to regulate cell growth and apoptosis by binding to cell surface Hyal-2 and inducing Hyal-2-WWOX complex formation for activating Smad-driven promoter in the nucleus (Figure 2) . The canonical Wnt/b-catenin axis is critical for development and tissue homeostasis. Dysregulation of Wnt/b-catenin signaling leading to aberrant activation of target genes may cause many diseases, including developmental disorders and cancers. The DVL proteins are essential effectors of Wnt/b-catenin signaling. Upon Wnt ligand stimulation, DVL proteins shuttle dynamically between the cytoplasm and nucleus and function as a hub in controlling the transcriptional activity of b-catenin-lymphoid enhancer-binding factor 1 (LEF1)/T cell-specific TCF complexes in the nucleus. WWOX interacts with DVL2 and sequesters DVL2 in the cytoplasmic compartment, thereby inhibiting the function of DVL2 in facilitating b-catenin-LEF1/TCFmediated target gene expression ( Figure 2 ). 20 WWOX has been suggested to promote SH-SY5Y neuronal differentiation via inhibiting GSK-3b activity. 19 Whether WWOX modulates GSK-3b activity for controlling the activation of Wnt/b-catenin signal pathway is unknown. Whether WWOX regulates the developmental processes and cancer growth via its inhibition of Wnt/b-catenin signaling pathway remains to be determined.
Chemotherapeutic drug susceptibility is associated with WWOX-mediated cancer cell death
Verrucous carcinoma is a distinctive variant of SCC. Continuous intra-arterial infusion of a folate antagonist methotrexate (MTX) resulted in complete tumor regression in patients with verrucous carcinoma. 42 MTX treatment upregulates WWOX expression along with caspase activation and apoptotic cell death in both SCC tumor biopsies and cancer cell lines. 42 Upregulation of WWOX expression increases chemotherapeutic drug-induced apoptosis by dampening autophagy in MTX-sensitive SCC cancer cells. 42 Autophagy, a conserved intracellular catabolic process, has been suggested to facilitate the survival of rapidly growing cancer cells that have outgrown their vascular supply and encounter oxygen shortage or metabolic stress. Autophagy may also help cancer cells fight off chemotherapeutic drug-induced stress responses. WWOX triggers autophagy-inhibitory mTOR signaling and downregulates the expression of autophagy-essential proteins Atg12-Atg5, Beclin-1, and LC3-II in MTX-sensitive SCC cells (Figure 3 ). 42 In contrast, autophagy is highly active in MTX-resistant SCC cells (Figure 3) . The failure to induce WWOX upregulation in these SCC cells has been demonstrated to be associated with chemoresistance. 42 WWOX interacts with ÁNp63a and inhibits its function for sensitizing human osteosarcoma cell line SAOS2 to cisplatin-induced apoptosis (Figure 3 ). 45 Knockdown of WWOX expression in MCF7 cells leads to estrogen receptor-a downregulation and tamoxifen resistance, and facilitates anchorage-independent breast cancer cell growth. 62 The reduced expression of WWOX protein and increased nuclear accumulation of AP2g are associated with tamoxifen resistance in patients with advanced breast cancer. 63 Collectively, these studies indicate that WWOX is associated with anticancer drug-induced cell apoptosis, and suggest important implications for the potential use of tumor suppressor WWOX as a chemotherapeutic target for cancer treatment.
Conclusions and perspectives
Emerging evidence suggests that WWOX regulates cancer development and progression. As Wwox knockout mice die early in life from multiple physiological defects before the development of cancers, organ-or tissue-specific ablation of Wwox gene in mice will help unravel the subtleties of WWOX action in cancer pathogenesis. High WWOX expression in tissue specimens from cancer patients has been found to be associated with increased disease-free survival. The fragile WWOX gene can be considered as a potential prognostic biomarker of human cancers. WWOX is involved in many signaling pathways for regulating cell apoptosis, autophagy, differentiation, and metabolism. WWOX sensitizes cancer cells to chemotherapeutic drugs via suppressing autophagy and blocking prosurvival effector proteins. WWOX is apparently an attractive target for therapeutic intervention in cancers. Conceivably, delineation of the molecular mechanism by which WWOX regulates chemotherapeutic drug-induced cell apoptosis will have a great impact on our understanding of cancer treatment. Recent studies have suggested that WWOX acts as a regulator in metabolic processes. The regulatory roles of WWOX in these effects will be fascinating goals for future studies.
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